Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Decision Resources Group
The Competitive Landscape Will Be Significantly Impacted by Zimmer's Acquisition of Biomet, According to Findings from Decision Resources Group
BURLINGTON, Mass., June 5, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States large-joint reconstructive implant market will grow to a value of $8.8 billion in 2022, primarily as a result of the aging population because the elderly are most at risk of developing severe osteoarthritis. Market growth will, however, be dampened by the increasing activity of group purchasing organizations, which allow hospitals to buy products such as reconstructive implants in bulk at a discount. As a result, market expansion will be modest through 2022.
Other key findings from Decisions Resources Group's coverage of the U.S. large-joint reconstructive implant market:
Comments from Decision Resources Group Senior Analyst Brady Baker:
About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Decision Resources Group
©2012 PR Newswire. All Rights Reserved.